Clinical Trial

Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is a multicenter, double-blind, active-controlled, randomized, parallel, phase IV clinical trial to evaluate the efficacy and safety of DA-5218 in patients with type 2 diabetes who have inadequate glycemic control with metformin
Trial Details
NCT Number NCT07229534
Lead Sponsor Dong-A ST Co., Ltd.
Conditions Diabete Mellitus
Enrollment 238 participants
Start Date 2025-11
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-11-17